Skip to main content
978-487-1100

Enrichment of Full AAV2 Using Multicolumn Countercurrent Solvent Gradient Purification (MCSGP)

Read our latest article on enhancing Adeno-associated virus (AAV) purity for gene therapy titled Enrichment of Full AAV2 Using Multicolumn Countercurrent Solvent Gradient Purification (MCSGP). AAVs are powerful delivery vehicles, but separating full (therapeutic) from empty capsids has been a significant hurdle.

This research introduces a twin-column multicolumn countercurrent solvent gradient purification (MCSGP) process that dramatically improves the ratio of full to empty capsids. The results are impressive:

  • Increased full capsid content: From 30% to 68% (ddPCR) and 27% to 61% (cryo-TEM)!
  • Overcame yield-purity trade-off: Enhanced full capsid recovery while boosting purity.
  • Improved productivity: Up to 23% increase compared to batch methods.
  • Reduced buffer consumption: Up to 27% decrease, offering economic and environmental benefits.

This innovative MCSGP process is a game-changer for meeting the growing demand for high-quality AAV products, pushing us closer to more effective and safer gene therapies.

Read the article here: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.29036

Posted on July 16, 2025.

Related Posts

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.
Read More

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.
Read More

September 9, 2026

Tecnologias Analíticas para Peptídeos Terapêuticos- Portuguese

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.
Read More

Designed and developed by